Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4800463
Max Phase: Preclinical
Molecular Formula: C15H21NO2
Molecular Weight: 247.34
Molecule Type: Unknown
Associated Items:
ID: ALA4800463
Max Phase: Preclinical
Molecular Formula: C15H21NO2
Molecular Weight: 247.34
Molecule Type: Unknown
Associated Items:
Canonical SMILES: CC1CC(OC(=O)c2ccccc2)CC(C)(C)N1
Standard InChI: InChI=1S/C15H21NO2/c1-11-9-13(10-15(2,3)16-11)18-14(17)12-7-5-4-6-8-12/h4-8,11,13,16H,9-10H2,1-3H3
Standard InChI Key: ZYHGIAPHLSTGMX-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: Yes | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 247.34 | Molecular Weight (Monoisotopic): 247.1572 | AlogP: 2.76 | #Rotatable Bonds: 2 |
Polar Surface Area: 38.33 | Molecular Species: BASE | HBA: 3 | HBD: 1 |
#RO5 Violations: 0 | HBA (Lipinski): 3 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: | CX Basic pKa: 10.29 | CX LogP: 2.73 | CX LogD: 0.00 |
Aromatic Rings: 1 | Heavy Atoms: 18 | QED Weighted: 0.82 | Np Likeness Score: 0.60 |
1. Ellen Van Damme. (2021) Screening of ~5500 FDA-approved drugs and clinical candidates for anti-SARS-CoV-2 activity, [10.6019/CHEMBL4651402] |
Source(1):